Researchers sought to determine whether daily sulindac would reduce breast density in postmenopausal women with a history of stage 0-I breast cancer treated with aromatase inhibitors.
A structured interview study sought to understand patient experiences after being withdrawn from a cancer clinical trial.
A survey on supportive care needs revealed patients’ concerns regarding declining physical abilities, loved ones’ worries, and financial burdens.
No significant difference in SRE risk on the basis of intravenous bisphosphonate dosing was observed for patients with newly diagnosed multiple myeloma.
Researchers studied a total of 1903 cases of pediatric melanoma and patients were 54.4% female, the mean age was 12.4 years, and 89.8% were White.
An analysis of a registry of patients with CML and Philadelphia chromosome-positive ALL demonstrated that ponatinib is efficacious in those with relapsed or refractory disease.
Researchers sought to assess the disease-specific costs for Medicare recipients with multiple myeloma.
A retrospective study revealed age-based risks for toxicities in patients with NHL treated with high-dose chemotherapy and autologous hematopoietic cell transplantation.
Researchers sought to determine which hematopoietic stem cell transplantation procedure is more efficacious for patients with refractory/relapsed peripheral T-cell lymphoma.
An analysis of data from CheckMate 227 compared costs, ICERs, and QALYs for the dual immune checkpoint inhibitor therapy with those of platinum-doublet chemotherapy.
